Assessing the efficacy and safety in novel drug candidates for Alzheimer's disease utilizes a rigorous evaluation system. Preclinical studies usually involve in vitro and in vivo models to assess its potential effectiveness in targeting disease-related pathways. Once promising candidates emerge, they progress through clinical trials that are condu